These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3820145)

  • 1. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use.
    Graham CA; Sherwin BB
    J Psychosom Res; 1987; 31(1):45-53. PubMed ID: 3820145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study.
    Walker A; Bancroft J
    Psychosom Med; 1990; 52(1):86-96. PubMed ID: 2305025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
    Bancroft J; Rennie D
    J Psychosom Res; 1993; 37(2):195-202. PubMed ID: 8463994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of various oral contraceptive combinations on premenstrual symptoms.
    Andersch B
    Int J Gynaecol Obstet; 1982 Dec; 20(6):463-9. PubMed ID: 6130993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
    Brown C; Ling F; Wan J
    J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
    Almagor M; Ben-Porath YS
    J Psychosom Res; 1991; 35(6):721-8. PubMed ID: 1791586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to self-reporting of the pre-menstrual syndrome.
    Warner P; Bancroft J
    Br J Psychiatry; 1990 Aug; 157():249-60. PubMed ID: 2224376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inconvenience due to women's monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe.
    Lete I; Häusler G; Pintiaux A; Jamin C; Nappi RE; Fiala C; Chabbert-Buffet N; Lobo P
    Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):354-359. PubMed ID: 29157023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
    Mansour D
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():35-41; discussion 42-3. PubMed ID: 12659405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of psychological state associated with the menstrual cycle in users of oral contraception.
    Marriott A; Faragher EB
    J Psychosom Res; 1986; 30(1):41-7. PubMed ID: 3701666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration.
    Joffe H; Cohen LS; Harlow BL
    Am J Obstet Gynecol; 2003 Dec; 189(6):1523-30. PubMed ID: 14710055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric complications of progesterone and oral contraceptives.
    Glick ID; Bennett SE
    J Clin Psychopharmacol; 1981 Nov; 1(6):350-67. PubMed ID: 7037875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood, sexuality, oral contraceptives and the menstrual cycle.
    Warner P; Bancroft J
    J Psychosom Res; 1988; 32(4-5):417-27. PubMed ID: 3236269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
    Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral contraceptives and some psychological factors on the menstrual experience.
    Harding CM; Vail C; Brown R
    J Biosoc Sci; 1985 Jul; 17(3):291-304. PubMed ID: 4040913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.